In the News
Read the latest articles featuring MTPConnect
Job-ready clinical trial interns
Australian Health Journal | 13 December 2022
QUT training program receives funding to accelerate Australian medical device innovations
Mirage News | 6 December 2022
Breakthrough cancer research recognised for excellence
AusHealth News | 6 December 2022
Sovereign Capability Uplifted - Launch of Good Manufacturing Practice (GMP) Training for human health products
Australian Health Journal | 25 November 2022
MIPS researcher scores sought-after placement with CSL
Monash University | 21 November 2022
MTPConnect announces 16 REDI Fellowships in industry roles
BiotechDispatch | 15 November 2022
Stem Cells Market Size to be Worth $31.6 by 2030 at CAGR of 11.4%: Grand View Research Inc.
CISION PR Newwire | 27 October 2022
New funding for Bridge Program
Mirage News | 26 October 2022
New funding for Bridge Program
The National Tribune | 26 October 2022
New funding for Bridge Program
QUT News | 26 October 2022
15 medical research and technology projects receive millions of funding
HealthcareChannel | 25 October 2022
$1.5M funding awarded for new APAS® instrument
LISTCORP. | 24 October 2022
Funding success for Sydney cardiac & diabetes researchers
Mirage News | 21 October 2022
$16.9M for cutting edge medical innovations
Medical Buyer | 21 October 2022
First-of-its-kind health app to be trialled for young people managing diabetes and mental health
Western Sydney University | 21 October 2022
MTPConnect announces Round 2 funding to accelerate transformative diabetes and cardiovascular disease innovations
AusHSI | 21 October 2022
Funding success for Sydney cardiac & diabetes researchers
The National Tribune | 21 October 2022
$16.9 million for cutting edge medical innovations
BioMelbourne Network | 21 October 2022
Minds of Melbourne Connect: Associate Professor Elif Ekinci at the Australian Centre for Accelerating Diabetes Innovations
The University of Melbourne, Melbourne Connect | 4 October 2022
BTB Initiative wraps up with impact
Uniquest | 14 September 2022
Clinical Translation & Commercialisation Medtech (CTCM) Round 2 Now Open
TCF Services Newsletter | 9 September 2022
New Clincial Entrepreneurship Program to support skills growth for Australian healthcare professionals
University of Melbourne, Research | 6 September 2022
New Clinical Entrepreneur Program Officially Launched
The University of Western Australia News | 6 September 2022
Launch of new Australian Clinical Entrepreneur Program
Government of Western Australia | 5 September 2022
Adelaide BioMed City (ABMC) advances as SA's health and medical research commercialisation catalyst, announcing a new Board and partnership with MTPConnect
Adelaide BioMed City News | 1 September 2022
Starpharma wins recognition for development of COVID-19 antiviral nasal spray
Biotech Dispatch | 30 August 2022
Join MTPConnect's Australian delegation to the MedTech Conference in Boston in October
BioMelbourne Network | 25 August 2022
2022 WA Health Hackathon Recap
WA Data Science Innovation Hub | 24 August 2022
CSIRO opens 'missing link' lab to developing Australian vaccine pipeline
Biotech Dispatch | 11 August 2022
CTCM Round 2 Expressions of Interest Open 9 September 2022
Medical Technology Association of Australia | 3 August 2022
MTPConnect Commercialisation Program opens soon
Israel Inspired by Innovation - Israel Trade and Economic Commission, Sydney | 1 August 2022
MTPConnect-backed national biologics manufacturing facility opened by industry minister
Australian Manufacturing | 11 August 2022
MTPConnect's CTCM program launches next funding opportunity to boost commercialisation of Australian medical devices
Australian Manufacturing | 29 July 2022
MTPConnect commercialisation program opens soon
Innovation Aus | 28 July 2022
MTPConnect launches funding opportunity for medtech players in Australia
Agadir Group | 28 July 2022
MTPConnect launches funding opportunity for medtech players in Australia
BioSpectrum Asia | 28 July 2022
MTPConnect launches next funding opportunity for medical device companies
Health Dispatch | 27 July 2022
TGA's new report on cell and gene therapy regulation
BIoPharma Dispatch | 22 July 2022
GSK boss shares industry insights and experiences with research graduates
BIoPharma Dispatch | 21 June 2022
MTPConnect’s REDI Fellowship Program Re-opens
Startup News WA | 30 May 2022
Two WA projects win major medtech grants
Startup News WA | 18 May 2022
MTPConnect's REDI Fellowship Program Re-Opens - Call for Industry Sponsors to Apply for Final Round
Australian Manufacturing | 17 May 2022
UniSA Develops First-in-Human Trial for Aggressive Brain Tumours
OpenGov Asia | 17 May 2022
$4.5 million in fellowships for MedTech and BioTech stars
InnovationAus | 14 May 2022
BPH’s investee Cortical Dynamics awarded AU$137,000 by MTPConnect
Kalkin Media | 13 May 2022
Australia drives medical product development with new initiatives
Biospectrum Asia | 13 May 2022
University of Sydney researchers awarded REDI Industry Fellowships
The University of Sydney | 13 May 2022
MTPConnect's REDI contestable program training contract awarded to CBE Consortium
CBE | 12 May 2022
Proteomics International (ASX:PIQ) awarded funding to support diabetic kidney disease test development
The Market Herald | 12 May 2022
ARCS GROW Program ready to branch out
ARCS Australia | 12 May 2022
Further boost for Australian Medtech Research Commercialisation
University of Technology Sydney | 12 May 2022
West Australian based researcher Dr Cathy Sucher Awarded REDI Fellowship high priority project, with one of Australia’s most innovative companies
Ear Science Institute Australia | 12 May 2022
Fast-tracked: First in-human trial for aggressive brain tumours
University of South Australia | 12 May 2022
UTS pharmacy researcher awarded REDI Fellowship
University of Technology Sydney | 12 May 2022
REDI Fellowships for Medical Research
LaTrobe University | 12 May 2022
Bringing Industry and Academia Together in Australia
CSL Behring | 12 May 2022
Medical products sector a powerhouse of job creation – new report from MTPConnect
Australian Manufacturing | 29 April 2022
Stuart Dignam the new CEO of MTPConnect
BiotechDispatch | 26 April 2022
MTPConnect announces support for major new resilience projects
Biotech Dispatch | 7 April 2022
Huge funding boost to launch Australia’s first collaborative cardiovascular research accelerator
Mirage News | 15 January 2022
TTRA Grant Success: Victor Chang Cardiac Research Institute a founding member of the National Research Centre for Cardiovascular Disease
Victor Chang Cardiac Research Institute | 14 January 2022
$10m for national stroke & heart research translation accelerator
The University of Sydney | 14 January 2022
Huge funding boost to launch Australia's first collaborative cardiovascular research accelerator
Monash University | 14 January 2022
Research to target heart disease, diabetes
The Canberra Times | 14 January 2022
$21.8 million to turn medical research into better patient care
The Department of Health - Media release | 14 January 2022
Western Australia - $1m boost for medical products manufacturing
Australian Manufacturing Technology | 30 November 2021
Nirtek begins R&D collaboration with TTRA funding support
BiotechDispatch | 11 November 2021
$1m boost for WA medical products manufacturing
AMTIL In Industry News | 04 November 2021
Manufacturing grants for medical innovations
Business News | 04 November 2021
$1M boost for WA medical products manufacturing
Startup News WA | 03 November 2021
Australia well placed to meet growing demand for medicinal cannabis in the next decade
cannabiz | 26 October 2021
Grants to help manufacturers commercialise great ideas
Department of Industry, Science, Energy and Resources | 07 October 2021
Aussie tick spit breakthrough may be key to clot-busting stroke treatment
The Australian | 27 September 2021
More federal funding aims to improve the lives of Australians through health and medical research
Aged Care News | 27 September 2021
MTPConnect joins industry funding to government-backed research
BioPharma Dispatch | 24 September 2021
ANDHealth, MTPConnect share in early stage commercialisation grants
Pulse+IT | 23 August 2021
Gov’t backs medical innovation, research with $79m
InnovationAus | 20 August 2021
New report calls for change on reimbursement of regenerative medicines
BioPharmaDispatch | 13 August 2021
Strengthening Australia’s regenerative medicine value chain
Biotech Dispatch | 12 August 2021
Govt ‘stonewalls’ release of Growth Centres report
InnovationAus | 09 August 2021
Pharma in Focus | 04 August 2021
Labor tries to force release of growth centres report
InnovationAus | 04 August 2021
Covid study incorporating Dimerix’s DMX-200 adds more sites
Mirage News | 03 August 2021
Draft roadmap for Australian regenerative medicine released for comment
Biotech Dispatch | 29 July 2021
Fifteen manufacturers receive $7.1 million to commercialise products
Manufacturers Monthly | 23 July 2021
Interview: Christian Porter on the industry portfolio
InnovationAus | 23 July 2021
Dimerix (ASX:DXB) advances COVID-19 Phase 3 study, enrols multiple patients
Kalkin Media | 22 July 2021
“MTP’s next ‘guest of the chair’ Director level experience on offer”
Pharma In Focus | 21 July 2021
Patient Advocate gets Board Gig
MedNews | 21 July 2021
Govt dishes out $7m in commercialisation grants
InnovationAus | 20 July 2021
Australian manufacturers are growing Australian jobs through commercialisation fund
Manufacturing Magazine Industry Update | 20 July 2021
ABC Radio Nightlife | 19 July 2021
CRC program stands alone in federal industry support
InnovationAus | 19 July 2021
Biointelect: Come forward for support on securing investment
Health Dispatch | 14 July 2021
Australian Biotech Startup Vaxine Launch Clinical COVID19 Vaccine Trials in Iran
Grit Daily | 06 July 2021
In Iran, an Aussie startup hopes for COVID-19 vaccine success
SMH | 04 July 2021
Growth Centres are on their own from 2022
Innovation Aus | 07 June 2021
SECRET REPORT BACKS INDUSTRY GROWTH CENTRES, POINTS TO UNDER-FUNDING
AuManufacturing | 31 May 2021
Industry dept mulls Growth Centres’ future
Innovation Aus | 24 May 2021
Technology boosting already strong clinical trials sector
BioPharma Dispatch | 21 May 2021
Untapped potential in clinical trials sector
AusInnovation | 20 May 2021
Half a decade of domestic growth in the clinical trials sector has failed to attract a greater share of global industry-sponsored trials to Australia, according to a new report from the MedTech and pharmaceutical growth centre, which touts the sector’s potential in the COVID recovery.
Medtech grants of up to $100K on offer
Startup News WA | 19 May 2021
MTPConnect launches voucher program to support medical manufacturing
Manufacturers Monthly | 17 May 2021
MTPConnect, Australia’s growth centre for medical technologies and pharmaceuticals sector, has launched a new voucher program to boost the manufacture of medical products in Western Australia.
MedTech and pharma grants open in WA
AusInnovation | 17 May 2021
Western Australian developers and manufacturers can now apply for up to $100,000 in matched government funding for medical technology and pharmaceutical manufacturing projects.
MTPCONNECT MANUFACTURING VOUCHER PROGRAM LAUNCHED
AuManufacturing | 14 May 2021
MTPConnect urges industry support for new fellowships
BiotechDispatch | 13 May 2021
GSK bridges gap between academia and industry
Health Industry Hub | 13 May 2021
FDA awards Oncores Medical’s breast cancer innovation breakthrough device designation
Bioworld | 10 May 2021
Industry alliance to be the united voice for Australia’s genomics future
Health Industry Hub | 03 May 2021
New MTPConnect report highlights skill gap
BioPharmaDispatch | 11 March 2021
MTPConnect released the second of three reports examining skills gaps in the medical technology, biotechnology and pharmaceutical (MTP) sector workforce and identified 20 skills gaps. The reports are being developed as part of the Researcher Exchange and Development within Industry (REDI) initiative, operated by MTPConnect for the Medical Research Future Fund.
$38 million available for research into diabetes, heart disease
Department of Health | 12 January 2021
MTPConnect, together with the Minister for Health & Aged Care, Hon. Greg Hunt MP announced that that the Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease is calling for Expressions of Interest (EOI) for two new Research Centres and the first round of Research Projects funding.
GSK backs MTPConnect industry-researcher initiative
Biotech Dispatch | 19 November 2020
MTPConnect announced that GSK Australia had joined the REDI initiative as a partner to fun its new PhD Graduate Innovation Program.
New initiative to accelerate research for diabetes and cardiovascular disease
Biotech Dispatch | 29 October 2020
MTPConnect announced partners for its TTRA initiative - ANDHealth, the Medical Device Partnering Program (MDPP) and UniQuest that will provide advice and mentoring for funding recipients.
Industry backs new regenerative medicine consortium
Biotech Dispatch | 29 October 2020
MTPConnect announced that it had awarded Industry Growth Centre funding to establish a regenerative medicine consortium led by AusBiotech with six industry partners.
Funding for Brisbane-based clinical trial manufacturing facility
Biotech Dispatch | 15 October 2020
MTPConnect welcomed the funding for a new manufacturing facility at the Translational Research Institute (TRI) in Brisbane.
Report calls for long-term investment in pandemic R&D
Stockhead | 7 October 2020
MTPConnect, in partnership with L.E.K. Consulting, released the second edition of the COVID-19 Impact Report to explore the strategies to spur recovery and discusses trends and opportunities for growth. The report makes it clear that the MTP sector has a critical and ongoing role to play in pandemic response, future preparedness and economic recovery.
‘Pharma resistance’ to battle superbugs
The Australian | 24 September 2020
MTPConnect, with support from Pfizer, MSD Australia, GSK Australia and Medicines Australia launched Australia's first Antimicrobial Resistance Network – the AAMRNet, and released a new report, ‘Fighting Superbugs: A Report on the Inaugural Meeting of Australia’s Antimicrobial Resistance Stakeholders'.
Millions in funding for virus vaccine, treatment hope
The Australian | 3 September 2020
The article covers the announcement of BTB Round 2 & 3 funding to 13 early stage medical research projects.
Funding Boost for COVID-19 Research
Department of Health | 3 September 2020
MTPConnect joined Minister for Health Hon. Greg Hunt MP, in the announcement of 13 early-stage medical research projects (including 5 COVID-19 projects), recieving $10.4 million in funding from BTB Rounds 2 & 3.
AMTIL Magazine | 6 August 2020
Queensland's University of Technology (QUT)'s BridgeTech Program was highlighted in AMTIL's latest issue. BridgeTech is funded by MTPConnect with the REDI initiative.
$18.8M investment for Australian medtech research
Australian Manufacturing | 20 July 2020
MTPConnect announced the promising 21 research projects, funded under the third round of the BioMedTech Horizons program.
MTPConnect to administer new research accelerator
BiotechDispatch | 14 July 2020
MTPConnect launched its $47 million Targeted Translation Research Accelerator (TTRA) for Diabetes and Cardiovascular Disease, an initiative of the Medical Research Future Fund (MRFF), operated by MTPConnect.
Accelerating diabetes and cardiovascular disease research
Department of Industry, Science, Energy and Resources | 13 July 2020
The Minister for Industry, Science and Technology Hon. Karen Andrews MP joined Minister for Health Hon. Greg Hunt MP in the announcement of the new $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, awarded to MTPConnect.
Medtech sector ready to provide jobs and attract investment
Australian Financial Review | 13 July 2020
Our Managing Director & CEO Dr Dan Grant spoke about the potential for the MTP sector to develop in the short term post COVID-19 and more.
Australian Financial Review | 17 June 2020
Our Managing Director & CEO Dr Dan Grant highlighted our COVID-19 Impact Reports and the way our MTP sector and government are coming together to combat the global pandemic.
Innovation Aus | 18 May 2020
The call out for the third round of our Biomedical Translation Bridge (BTB) program, was centered around responding to the global pandemic in 12 months or less.
PM&C names digital advisory board
Innovation Aus | 1 March 2020
Our Chair Sue MacLeman, was appointed to the Prime Ministers Digital Health Advisory Committee.
$32 million to turn more research ideas into reality
Department of Health | 5 February 2020
MTPConnect along with our partners, were awarded REDI, a new MRFF program.
MTPConnect appoints experienced industry and R&D executive
Biotech Dispatch | 21 January 2020
Biotech Dispatch covered the announcement of our new Board member Alex Fowkes.
Startup wants to translate your tummy rumbles with AI
Sydney Morning Herald | 16 January 2020
Noisy Guts, a WA-based start-up, was awarded funding in the first round of our Biomedical Translation Bridge (BTB) Program.
Australia- India economic growth: Frugal innovation the key to driving business links for the future
Australian Manufacturing | 10 December 2019
This article highlights the launch of our report with Asialink Business and unpacking the India opportunity.
Australia takes BIO ‘by storm’ with largest ever delegation
BioWorld | 7 June 2019
BioWorld highlights the Australian delegation to BIO international convention and also features the How Global MedTech & Pharma Corporates Engage with Australia report in partnership with BioPacific Partners.
Investment in medical tech to pay healthy dividends
Business News | 4 June 2019
One year on from creating the MTPConnect WA Hub, the story examines the achievements of the Hub in partnership with the WA Government and UWA.
This small cap biotech proves it is possible to have more women than men on a board
Stockhead | 8 March 2019
Stockhead profiles MTPConnect's Chair Sue MacLeman on International Women's Day.
MTPConnect driving solid growth
InnovationAus | 21 February 2019
The story tracks the growth of MTPConnect from it's beginnings as part of the Department of Industry, Innovation and Science's Industry Growth Centre initiative.
$22 million to fast track early stage research
Department of Health | 18 February 2019
The Australian Government announced the development of the Biomedical Translation Bridge (BTB) Program with partners including, BioCurate, UniQuest, the Medical Device Partnering Program (MDPP) and the Bridge Program.
MTPConnect support for industry back digital health accelerator
Biotech Dispatch | 17 January 2019
MTPConnect has backed its project ANDHealth to continue its work on enhancing the Australian digital health sector.
MTPConnect's Dr Dan Grant: A new future for medical research funding
Biotech Dispatch (also featured in Pharma Dispatch) | 20 December 2018
MTPConnect CEO authored a blog for Biotech Dispatch on the new features in the MRFF and the possibilities for the future that was announced in December.
AusBiotech congratulates MTPConnect on new funding
Biotech Dispatch | 6 Decemember 2018
When it was announced that MTPConnect would receive additional funding to 2021, AusBiotech congratulated MTPConnect on the great news.
Australia poised for global success in regenerative medicine
The Mandarin | 16 November 2018
MTPConnect CEO Dr Dan Grant wrote an opinion piece on regenerative medicine in Australia and what opportunities there are for the sector.
Hope for regenerative medicine bonanza
The Australian | 31 October 2018
The Australian exclusively covered the launch of our regenerative medicine report at the AusBiotech Conference.
Health tech funding injection to propel Australian innovations to market and into Asia
Healthcare IT | 16 October 2018
Three MTPConnect projects - the Industry Mentoring Network in STEM (IMNIS), the Medical Device Partnering Program (MDPP) and Asialinks Business - have received funding from the MTPConnect Project Fund Program. IMNIS and MDPP were part of the 2016 round of the program and Asialinks is a new project.
BioSpace | 4 October 2018
International publication BioSpace shared the announcement of MTPConnect's new chair Sue MacLeman, taking over from our Chair Dr Bronwyn Evans who is stepping down after nearly two years of service.
Australian government growth centres invest in life sciences sector for future global growth
BioWorld | 25 September 2018
BioWorld journalist Tamra Sami interviewed MTPConnect CEO Dr Dan Grant in WA around the launch of the MTPConnect WA hub in September.
Innovation is part of Australia's DNA. We must help commercialise it
The Australian Financial Review | 30 July 2018
Former Minister for Jobs and Innovation Senator Michaelia Cash wrote an opinion piece for the AFR in July around the AFR Innovation Summit.
MTPConnect Launches Western Australian Node
Manufacturer's Monthly | 4 July 2018
MTPConnect's Chair Dr Bronwyn Evans supported the launch of the MTPConnect WA Node in partnership with the Western Australian Government and the University of Western Australia at the Harry Perkins Institute and Centre for Medical Research.
Australia makes its mark in biotechnology
Nature Journal | 9 May 2018
MTPConnect CEO Sue MacLeman spoke with Nature, a scientific journal about how Australia is making its mark in biotechnology.
Dr Dan Grant appointed as new CEO of MTPConnect
Lab and Life Scientist | 7 May 2018
Dr Dan Grant was announced as MTPConnect's CEO-elect bringing with him many years of experience in the sector, where he will be starting in July.
"We could lead the world": Australia's MTP sector shows it's punching above its weight
Healthcare IT | 19 April 2018
MTPConnect's CEO Sue MacLeman talks to Healthcare IT about the recent announcement of the amazing innovations of the MTPConnect-delivered, Department of Health's $10 million BioMedTech Horizons program.
$1 million funding boost for UOW's 'groundbreaking' Biopen
Illawara Mercury | 19 April 2018
The article focuses on the team behind the Biopen, one of the 11 selected participants who have received funding from the MTPConnect-delivered Department of Health's $10 million BioMedTech Horizons program.
$10m in funding awarded to 11 projects to boost health innovation
Manufacturer's Monthly | 18 April 2018
MTPConnect and the Minister for Health, Greg Hunt, have announced the first 11 recipients of $10 million investment from the government’s $35 million BioMedTech Horizons program.
MTPConnect and BioPacific Partners announce new initiative
Manufacturer's Monthly | 12 April 2018
MTPConnect and BioPacific Partners has jointly launched an exciting new initiative to assist Australian medical technology and pharmaceutical companies to better prepare and position themselves to engage successfully with multinational companies.
Why investors should pay attention to biotechs focused on China
Chinese demand has sparked ASX-listed food and resources stocks — but health innovators may benefit most, says MTP Connect CEO Sue MacLeman. Ms MacLeman also mentions our Project Fund Program recipient's AusBiotech Asian Investment Series in Hong Kong and Shanghai.
InnovationAus | 8 March 2018
MTPConnect CEO Sue MacLeman talks to Innovation Australia about creating gender diversity within the tech and innovation sector or lose global competitiveness in this critical arena on International Women's Day.
Strong growth in Australia's medtech, biotech and pharma sectors
Manufacturer's Monthly | 12 February 2018
MTPConnect has released new sector metrics that show jobs supported by the MTP sector increased by 10 per cent to 62,000 from 2015 to 2016, and that manufacturing exports are up by 30 per cent to $5.2 billion.
3D Printing And Precision Medicine To Get $5m In Government Funding
The Australian | 1 November 2017
Managed by MTPConnect, the $5m BioMedTech Horizons program will be managed by MTPConnect, the medical technologies and pharmaceuticals industry growth centre. MTPConnect chief executive Sue MacLeman spoke to The Australian, saying that 3D anatomical printing and precision medicine had been identified for the first share of funding because Australia punched above its weight in those areas.
Cancer Test Platform among Recipients in $22.5m Tech Funding Round For MTPConnect
Australian Financial Review | 26 October 2017
Our CEO Sue MacLeman talks about a MTPConnect Project Fund Program lead The Garvan Institute aimed to improve cancer clinical trial research.
AISC's new training package for pharma manufacturing Businesses
Manufacturer's Monthly | 11 August 2017
Our General Manager of Education, Skills and Events Dr Melanie Thomson about the training that will save pharmaceutical manufacturing businesses time and money by allowing employees to transfer basic skills between companies.
Pharma research play translates into jobs and growth
The Mandarin | 7 August 2017
An article discussing our Clinical Trials Report and how it aims to turn Australia around to be a destination for jobs and pharmaceutical investment in clinical trials.
Grant boost for medical research
Business News Western Australia | 1 November 2016
The MTPConnect Project Fund Program has provided a local WA consortium with a $150,000 grant to improve commercialisation of pharmaceutical and medical technologies.
New funding mechanism could create needed life sciences ecosystem
BioWorld | 28 October 2016
The Medical Technologies and Pharmaceuticals Industry Growth Centre (MTPConnect) announced at the recent AusBiotech annual conference that it would provide A$7.4 million (US$5.6 million) of funding over two years for 14 national projects in the med-tech, biotech and pharmaceutical sector, with the Australian government injecting more funding into its life sciences sector to help it become more globally competitive in commercializing products.
$43.4 million announced to drive innovation in pharmaceuticals and medtech around Australia
StartUp Smart | 24 October 2016
Growing investment in medical technology and pharmaceutical innovation is set to fire a new pipeline of high-impact ventures into Australia that have been hiding in the corridors of universities waiting to be commercialised. This week, non-profit organisation MTPConnect announced it will inject $7.4 million into 14 medtech, biotech and pharmaceutical projects over the next two years. The funding will be matched by a further $32 million from industry partners under MTP Connect’s project fund program.
Pill boxes and 'kneehab' apps: Johnson & Johnson hackathon
Australian Financial Review | 26 September 2016
Our CEO Sue MacLeman comments on the recent Federal Government response to the Review of Medicines and Medical Devices Regulation in this article highlighting Johnson & Johnson's potential commercialisation of two winning inventions from a hackathon earlier this month.
InnovationAus | 30 June 2016
Our CEO Sue MacLeman talked to InnovationAus about the achievements and challenges of the MTP sector and how MTPConnect will increase collaboration and commercialisation efforts.
A boost for innovation in medical technologies and pharmaceuticals sector
University of Sydney | 11 December 2015
Australia’s newest Growth Centre – the Medical Technologies and Pharmaceutical Industry Growth Centre – has been announced by the Hon. Christopher Pyne, Federal Minister for Industry, Innovation and Science and Minister for Health, Sussan Ley.